Breast Cancer
Oncotelic Therapeutics Venture Advances Novel Breast Cancer Treatment to Clinical Trials
Sapu Nano, an Oncotelic Therapeutics venture, has received Australian ethics approval to begin clinical trials for Sapu003, an injectable form of everolimus that could significantly improve breast cancer treatment outcomes by enabling full drug absorption through intravenous delivery.
Oncotelic Therapeutics to Present Novel Breast Cancer Treatment Data at 2025 Symposium
Oncotelic Therapeutics will present clinical data for its investigational breast cancer treatment Sapu003 at the 2025 San Antonio Breast Cancer Symposium, potentially offering improved efficacy and reduced toxicity for patients with HR⁺/HER2⁻ metastatic breast cancer.
Izotropic Corporation Featured in Editorial on AI-Driven Breast Cancer Imaging Innovation
Izotropic Corporation is highlighted in a NetworkNewsWire editorial focusing on how artificial intelligence is transforming breast cancer detection, particularly through the company's IzoView Breast CT Imaging System designed to improve accuracy for women with dense breast tissue.
AI-Driven Imaging Technology Targets Breast Cancer Detection Challenges in High-Growth Market
Artificial intelligence is transforming breast cancer detection by addressing limitations in traditional imaging methods, particularly for women with dense breast tissue, as companies develop advanced diagnostic solutions for a market facing significant patient demand.
AI-Enhanced 3D Imaging Technologies Transform Breast Cancer Detection in $9 Billion Market
Artificial intelligence is revolutionizing breast cancer diagnostics through advanced 3D imaging technologies that improve detection accuracy, particularly for women with dense breast tissue, addressing a critical global health challenge affecting millions of women annually.
Izotropic Integrates Personalized Radiation Dosing into Breast CT System, Positioning for Global Market Expansion
Izotropic Corporation has integrated a patent-pending radiation dose personalization feature into its IzoView Breast CT Imaging System, representing a significant advancement in breast cancer imaging technology with potential to improve patient safety and comfort while positioning the company for growth in the $8.69 billion global breast imaging market.
Izotropic's Proprietary AI Algorithm Trained on 15 Years of Breast CT Data Positions Technology to Redefine Global Imaging Standards
Izotropic Corporation has developed a proprietary machine-learning reconstruction algorithm using 15 years of breast CT data, creating sustainable competitive advantages in medical imaging through trade secret protection and modality-specific training.
Izotropic Secures Exclusive CADx Patent for AI-Enhanced Breast CT Imaging
Izotropic Corporation has obtained exclusive U.S. patent rights for computer-aided diagnosis with breast CT technology, positioning its IzoView system as a first-mover in AI-enhanced breast imaging with potential dual revenue streams through software upgrades and licensing.
Izotropic Corporation's IzoView Breast CT Aims to Transform Dense Breast Tissue Imaging Amid $8.7B Market Opportunity
Izotropic Corporation is developing the IzoView Breast CT system to address limitations in traditional mammography for patients with dense breast tissue, potentially reducing missed cancers and unnecessary follow-up costs in the $8.7 billion global breast imaging market.
Izotropic CEO Highlights Breast CT Imaging Breakthrough in Podcast Interview
Izotropic Corporation's CEO discussed the company's IzoView Breast CT Imaging System, which can detect breast cancers as small as 2 millimeters, potentially revolutionizing early detection and positioning the company as a takeover target.
Izotropic Launches BreastCT.com Educational Platform to Address Market Education Challenge for Breast Imaging Technology
Izotropic Corporation has launched BreastCT.com as a strategic educational platform to address the critical market awareness challenge facing breakthrough medical technologies, particularly for its IzoView breast CT system designed for dense breast tissue imaging.
Izotropic Corp. Launches Brand Transformation Ahead of Breast CT Technology Commercialization
Izotropic Corporation has unveiled a comprehensive brand identity transformation to position itself for the commercial launch of its revolutionary breast CT imaging technology targeting the $8.7 billion global breast imaging market.
Izotropic Corporation Unveils New Corporate Website and Brand Identity to Enhance Breast Cancer Imaging Technologies
Izotropic Corporation launches a redesigned website and refreshed brand identity to better communicate its advancements in breast cancer imaging technologies and commercialization strategy.
Izotropic Corp. Pioneers Next-Generation Breast Cancer Imaging with IzoView System
Izotropic Corp. is set to transform breast cancer detection with its IzoView Breast CT Imaging System, addressing critical gaps in screening precision, especially for women with dense breast tissue.
Izotropic Corporation Launches Multilingual Podcast to Educate on Breast Imaging Innovations
Izotropic Corporation introduces a multilingual podcast series to highlight the limitations of current breast imaging technologies and the potential of its IzoView Breast CT system, aiming to educate a global audience.
Izotropic Corporation Highlights Growing Demand for Breast CT Imaging Innovation Amid Rising Breast Cancer Cases
Izotropic Corporation's IzoView Breast CT Imaging System addresses the increasing global demand for advanced breast cancer imaging technologies, offering a more comfortable and accurate alternative to traditional methods.
Izotropic Corp. Advances Breast Cancer Imaging with Exclusive Breast CT Technology
Izotropic Corp. is pioneering a patient-centric alternative to mammography for dense breast tissue imaging, with exclusive global rights to Breast CT technology and upcoming U.S. clinical trials.
Izotropic Corporation Launches Awareness Campaign for IzoView Breast CT Imaging System
Izotropic Corporation initiates a strategic awareness campaign to educate on its IzoView Breast CT Imaging System, aiming to align investor and market engagement before commercialization.
Keep A Breast Foundation Marks 25 Years with Star-Studded Anniversary Celebration
The Keep A Breast Foundation celebrates a quarter-century of breast cancer prevention and education with a special anniversary party, featuring performances by Arrested Development and Shepard Fairey, to fund its new wellness retreat center, KAB Valley.